Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Dual ╬▓-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition.

Siriyong T, Murray RM, Bidgood LE, Young SA, Wright F, Parcell BJ, Voravuthikunchai SP, Coote PJ.

Sci Rep. 2019 Jun 24;9(1):9098. doi: 10.1038/s41598-019-45550-z.

2.
3.

Evaluation of greater wax moth larvae, Galleria mellonella, as a novel in vivo model for non-tuberculosis Mycobacteria infections and antibiotic treatments.

Entwistle FM, Coote PJ.

J Med Microbiol. 2018 Apr;67(4):585-597. doi: 10.1099/jmm.0.000696. Epub 2018 Feb 13.

PMID:
29458557
4.

Effective immunosuppression with dexamethasone phosphate in the Galleria mellonella larva infection model resulting in enhanced virulence of Escherichia coli and Klebsiella pneumoniae.

Torres MP, Entwistle F, Coote PJ.

Med Microbiol Immunol. 2016 Aug;205(4):333-43. doi: 10.1007/s00430-016-0450-5. Epub 2016 Feb 26.

5.

Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.

Adamson DH, Krikstopaityte V, Coote PJ.

J Antimicrob Chemother. 2015 Aug;70(8):2271-8. doi: 10.1093/jac/dkv111. Epub 2015 Apr 28.

PMID:
25921513
6.

A Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa.

Krezdorn J, Adams S, Coote PJ.

J Med Microbiol. 2014 Jul;63(Pt 7):945-55. doi: 10.1099/jmm.0.074245-0. Epub 2014 Jun 13.

PMID:
24928215
7.

Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection.

Hill L, Veli N, Coote PJ.

Int J Antimicrob Agents. 2014 Mar;43(3):254-61. doi: 10.1016/j.ijantimicag.2013.11.001. Epub 2013 Dec 1.

PMID:
24361354
8.

MRSA decolonization of cotton rat nares by a combination treatment comprising lysostaphin and the antimicrobial peptide ranalexin.

Desbois AP, Sattar A, Graham S, Warn PA, Coote PJ.

J Antimicrob Chemother. 2013 Nov;68(11):2569-75. doi: 10.1093/jac/dkt243. Epub 2013 Jun 25.

PMID:
23800902
9.

Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection.

MacCallum DM, Desbois AP, Coote PJ.

Eur J Clin Microbiol Infect Dis. 2013 Aug;32(8):1055-62. doi: 10.1007/s10096-013-1850-8. Epub 2013 Apr 10.

PMID:
23572153
10.

A model for 3-methyladenine recognition by 3-methyladenine DNA glycosylase I (TAG) from Staphylococcus aureus.

Zhu X, Yan X, Carter LG, Liu H, Graham S, Coote PJ, Naismith J.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jun 1;68(Pt 6):610-5. doi: 10.1107/S1744309112016363. Epub 2012 May 22.

11.

Utility of Greater Wax Moth Larva (Galleria mellonella) for Evaluating the Toxicity and Efficacy of New Antimicrobial Agents.

Desbois AP, Coote PJ.

Adv Appl Microbiol. 2012;78:25-53. doi: 10.1016/B978-0-12-394805-2.00002-6.

PMID:
22305092
12.

Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents.

Desbois AP, Coote PJ.

J Antimicrob Chemother. 2011 Aug;66(8):1785-90. doi: 10.1093/jac/dkr198. Epub 2011 May 28.

PMID:
21622972
13.

Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus.

Overton IM, Graham S, Gould KA, Hinds J, Botting CH, Shirran S, Barton GJ, Coote PJ.

BMC Syst Biol. 2011 May 12;5:68. doi: 10.1186/1752-0509-5-68.

14.

Survey of small antifungal peptides with chemotherapeutic potential.

Desbois AP, Tsch├Ârner D, Coote PJ.

Curr Pharm Biotechnol. 2011 Aug;12(8):1263-91. Review.

PMID:
21470150
15.

Bactericidal synergy of lysostaphin in combination with antimicrobial peptides.

Desbois AP, Coote PJ.

Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):1015-21. doi: 10.1007/s10096-011-1188-z. Epub 2011 Feb 11.

PMID:
21311938
16.

The Scottish Structural Proteomics Facility: targets, methods and outputs.

Oke M, Carter LG, Johnson KA, Liu H, McMahon SA, Yan X, Kerou M, Weikart ND, Kadi N, Sheikh MA, Schmelz S, Dorward M, Zawadzki M, Cozens C, Falconer H, Powers H, Overton IM, van Niekerk CA, Peng X, Patel P, Garrett RA, Prangishvili D, Botting CH, Coote PJ, Dryden DT, Barton GJ, Schwarz-Linek U, Challis GL, Taylor GL, White MF, Naismith JH.

J Struct Funct Genomics. 2010 Jun;11(2):167-80. doi: 10.1007/s10969-010-9090-y. Epub 2010 Apr 24.

17.

In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.

Desbois AP, Gemmell CG, Coote PJ.

Int J Antimicrob Agents. 2010 Jun;35(6):559-65. doi: 10.1016/j.ijantimicag.2010.01.016. Epub 2010 Mar 4.

PMID:
20206480
18.

Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.

Harris MR, Coote PJ.

Int J Antimicrob Agents. 2010 Apr;35(4):347-56. doi: 10.1016/j.ijantimicag.2009.11.021. Epub 2010 Jan 27.

PMID:
20106636
19.

Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).

Desbois AP, Lang S, Gemmell CG, Coote PJ.

J Appl Microbiol. 2010 Feb;108(2):723-30. doi: 10.1111/j.1365-2672.2009.04472.x. Epub 2009 Jul 13.

20.
21.

A novel role for the yeast protein kinase Dbf2p in vacuolar H+-ATPase function and sorbic acid stress tolerance.

Makrantoni V, Dennison P, Stark MJR, Coote PJ.

Microbiology. 2007 Dec;153(Pt 12):4016-4026. doi: 10.1099/mic.0.2007/010298-0.

PMID:
18048916
22.

Expression, purification, crystallization, data collection and preliminary biochemical characterization of methicillin-resistant Staphylococcus aureus Sar2028, an aspartate/tyrosine/phenylalanine pyridoxal-5'-phosphate-dependent aminotransferase.

Seetharamappa J, Oke M, Liu H, McMahon SA, Johnson KA, Carter L, Dorward M, Zawadzki M, Overton IM, van Niekirk CA, Graham S, Botting CH, Taylor GL, White MF, Barton GJ, Coote PJ, Naismith JH.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 May 1;63(Pt 5):452-6. Epub 2007 Apr 28.

23.

Purification, crystallization and data collection of methicillin-resistant Staphylococcus aureus Sar2676, a pantothenate synthetase.

Seetharamappa J, Oke M, Liu H, McMahon SA, Johnson KA, Carter L, Dorward M, Zawadzki M, Overton IM, van Niekirk CA, Graham S, Botting CH, Taylor GL, White MF, Barton GJ, Coote PJ, Naismith JH.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Jun 1;63(Pt 6):488-91. Epub 2007 May 5.

24.
25.
26.
27.

A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol.

Lambert RJ, Skandamis PN, Coote PJ, Nychas GJ.

J Appl Microbiol. 2001 Sep;91(3):453-62.

28.

Localization of GerAA and GerAC germination proteins in the Bacillus subtilis spore.

Hudson KD, Corfe BM, Kemp EH, Feavers IM, Coote PJ, Moir A.

J Bacteriol. 2001 Jul;183(14):4317-22.

29.

Identification and characterization of an ATP binding cassette L-carnitine transporter in Listeria monocytogenes.

Fraser KR, Harvie D, Coote PJ, O'Byrne CP.

Appl Environ Microbiol. 2000 Nov;66(11):4696-704.

30.

Germination-induced bioluminescence, a route to determine the inhibitory effect of a combination preservation treatment on bacterial spores.

Ciarciaglini G, Hill PJ, Davies K, McClure PJ, Kilsby D, Brown MH, Coote PJ.

Appl Environ Microbiol. 2000 Sep;66(9):3735-42.

31.
34.

Synergistic antibacterial action of heat in combination with nisin and magainin II amide.

Ueckert JE, ter Steeg PF, Coote PJ.

J Appl Microbiol. 1998 Sep;85(3):487-94.

35.

Inhibitory action of a truncated derivative of the amphibian skin peptide dermaseptin s3 on Saccharomyces cerevisiae.

Coote PJ, Holyoak CD, Bracey D, Ferdinando DP, Pearce JA.

Antimicrob Agents Chemother. 1998 Sep;42(9):2160-70.

36.
37.
38.

Activity of the plasma membrane H(+)-ATPase is a key physiological determinant of thermotolerance in Saccharomyces cerevisiae.

Coote PJ, Jones MV, Seymour IJ, Rowe DL, Ferdinando DP, McArthur AJ, Cole MB.

Microbiology. 1994 Aug;140 ( Pt 8):1881-90.

PMID:
7921241
39.
40.

TPK gene products mediate cAMP-independent thermotolerance in Saccharomyces cerevisiae.

Coote PJ, Jones MV, Edgar K, Cole MB.

J Gen Microbiol. 1992 Dec;138(12):2551-7.

PMID:
1336794
41.
42.

Supplemental Content

Loading ...
Support Center